Skip to main content
Displaying 171 of 2959 articles.
Prior infections appear to shield enteric neurons, preventing these key components of the body's "second brain" from dying off when future pathogens strike.

The new experimental system will facilitate efforts to study different coronavirus variants and develop new drugs for
  • Read more

  • The compound works by hindering a key pathway that cancer cells rely upon to hoard energy, and is already undergoing clinical trials.


    Human cells can be coaxed into preventing certain enveloped viruses (including HIV, Ebola, and parainfluenza) from escaping their membranes in the lab, a finding that could lead to novel treatments for many viral diseases.

    Studying dozens of naturally occurring and laboratory-selected mutations in SARS-CoV-2, researchers found that the virus will need to pull off a genetic feat to become fully resistant to antibodies.

    Scientists identified a mutation that affects one’s reaction to HPV by decreasing the production of CD28, a vital molecule within the immune system.

    People who recover from COVID-19 may have better protection than those who received a vaccine, but the benefits of natural immunity do not outweigh the very real risk of disability and death from contracting the disease.

    New studies point to a single molecular explanation for 20 percent of critical COVID-19 cases: insufficient or defective type I interferons.

    Not every gene that's essential in tuberculosis is also vulnerable to attack. A new study ranks essential genes by vulnerability, allowing researchers to better prioritize future drug targets.

    Helper T cells may play a dual role in the immune system, both encouraging and suppressing the process by which B cells mature.